"10.1371_journal.pone.0095496","plos one","2014-04-22T00:00:00Z","Surender Khurana; Elizabeth M Coyle; Milena Dimitrova; Flora Castellino; Karl Nicholson; Giuseppe Del Giudice; Hana Golding","Division of Viral products, Center for Biologics Evaluation and Research (CBER), Food and Drug Administration (FDA), Bethesda, Maryland, United States of America; Novartis Vaccines and Diagnostics Srl, Sienna, Italy; Department of Infection, Inflammation, and Immunity, Maurice Shock Medical Sciences Building, University of Leicester, Leicester, United Kingdom","Conceived and designed the experiments: SK HG. Performed the experiments: SK EMC MD. Analyzed the data: SK EMC MD. Contributed reagents/materials/analysis tools: SK FC KN GDG. Wrote the paper: SK HG.","Surender Khurana, Hana Golding, Elizabeth Coyle, and Milena Dimitrova are employees of the US FDA and have no competing interests. Karl Nicholson (Department of Inflammation, Infection, and Immunity, University of Leicester, UK, does not have any competing interests. Giuseppe Del Giudice and Flora Castellino are employees of Novartis vaccines and members of the Translation Medicine group. They provided the blinded samples to the Golding lab and were not involved in the designing, the execution, or the interpretation of the results. MF59 is a registered trademark of Novartis AG. This does not alter the authorsâ€™ adherence to PLOS ONE policies on sharing data and materials.","2014","04","Surender Khurana","SK",7,FALSE,2,3,3,2,TRUE,TRUE,FALSE,0,NA,FALSE
